Search Results - "GODIER, A"

Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease by GODIER, A., HUNT, B. J.

“…Plasminogen is the proenzyme of plasmin, the key protease of the fibrinolytic system, but its role is not limited to fibrinolysis regulation. Plasminogen binds…”
Get full text

French lyophilized plasma versus fresh frozen plasma for the initial management of trauma‐induced coagulopathy: a randomized open‐label trial by Garrigue, D., Godier, A., Glacet, A., Labreuche, J., Kipnis, E., Paris, C., Duhamel, A., Resch, E., Bauters, A., Machuron, F., Renom, P., Goldstein, P., Tavernier, B., Sailliol, A., Susen, S.

“…Essentials An immediate supply of plasma in case of trauma‐induced coagulopathy is required. The Traucc trial compared French Lyophilised Plasma (FLyP) and…”
Get full text

Impact of platelet transfusion on outcomes in trauma patients by Hamada, S R, Garrigue, D, Nougue, H, Meyer, A, Boutonnet, M, Meaudre, E, Culver, A, Gaertner, E, Audibert, G, Vigué, B, Duranteau, J, Godier, A

“…Trauma-induced coagulopathy includes thrombocytopenia and platelet dysfunction that impact patient outcome. Nevertheless, the role of platelet transfusion…”
Get full text

Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH by Godier, A., Greinacher, A., Faraoni, D., Levy, J. H., Samama, C. M.

Get full text

Compliance with evidence-based clinical management guidelines in bleeding trauma patients by Godier, A., Bacus, M., Kipnis, E., Tavernier, B., Guidat, A., Rauch, A., Drumez, E., Susen, S., Garrigue-Huet, D.

“…In 2007, the multidisciplinary European Task Force for Advanced Bleeding Care in Trauma published guidelines for the management of the bleeding trauma patient…”
Get full text

Use of factor concentrates for the management of perioperative bleeding: reply by Godier, A., Greinacher, A., Faraoni, D., Levy, J. H., Samama, C. M.

Get full text

Distinct patterns of circulating endothelial cells in pulmonary hypertension by SMADJA, D. M, MAUGE, L, SANCHEZ, O, SILVESTRE, J.-S, GUERIN, C, GODIER, A, HENNO, P, GAUSSEM, P, ISRAËL-BIET, D

“…The respective abundance of circulating endothelial cells and endothelial progenitor cells may reflect the balance between vascular injury and repair. As…”
Get full text

Multimodal assessment of non‐specific hemostatic agents for apixaban reversal by Martin, A.‐C., Gouin‐Thibault, I., Siguret, V., Mordohay, A., Samama, C.‐M., Gaussem, P., Le Bonniec, B., Godier, A.

“…Summary Background Non‐specific hemostatic agents, namely activated prothrombin complex concentrate (aPCC), PCC and recombinant activated factor (F) VII…”
Get full text

Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR) by Godier, A, Garrigue, D, Lasne, D, Fontana, P, Bonhomme, F, Collet, JP, de Maistre, E, Ickx, B, Gruel, Y, Mazighi, M, Nguyen, P, Vincentelli, A, Albaladejo, P, Lecompte, T

“…The French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Haemostasis and Thrombosis (GFHT) in collaboration with the French…”
Get full text

Treatment of massive bleeding with prothrombin complex concentrate: argument against by GODIER, A., SUSEN, S., SAMAMA, C.‐M.

“…See also Tanaka KA, Szlam F. Treatment of massive bleeding with prothrombin complex concentrate: argument for. This issue, pp 2589–91…”
Get full text

Management of the bleeding risk associated with antiplatelet agents by Martin, A-C, Houssany-Pissot, S, Zlotnik, D, Taylor, G, Godier, A

“…Like all antithrombotic drugs, antiplatelet agents expose to a risk of bleeding complications. Clinical research has extensively focused on the efficacy of…”
Get full text

Antiplatelet agents and transfusion by Gaussem, P, Martin, A-C, Belleville-Rolland, T, Helley, D, Bachelot-Loza, C, Godier, A

“…Antiplatelet agents are at risk for bleeding complications, the management of which differs depending on the clinical situation and on the antiplatelet agent…”
Get more information

Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH by Spyropoulos, A. C., Albaladejo, P., Godier, A., Greinacher, A., Hron, G., Levy, J. H., Samama, C. M., Douketis, J. D.

Get full text

State of the art: Direct oral anticoagulants and transfusion by Martin, A-C, Godier, A, Smadja, D M, Mauge, L, Fischer, A-M

“…Direct oral anticoagulants (DOAC) are indicated for stroke prevention in atrial fibrillation and for the prevention and treatment of venous thromboembolism. As…”
Get more information

User-friendly recommendations on antiplatelet agents: At last, a readable document by Samama, C M, Godier, A

Get full text

Management of massive bleeding in 2013: seven questions and answers by Godier, A, Samama, C M, Susen, S

“…The management of massive bleeding has improved, thanks to high-quality blood components and new transfusion strategies. However, it remains controversial and,…”
Get more information

Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference? by GODIER, A., DURAND, M., SMADJA, D., JEANDEL, T., EMMERICH, J., SAMAMA, C. M.

“…Background: Hydroxyethyl starches (HES) could differ with regard to the origin, and the influence on the coagulation of the raw material is unknown. This study…”
Get full text

Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit by Le Saché, F., Le Bonniec, B., Gaussem, P., Dizier, B., Tagzirt, M., Godier, A., Emmerich, J., Samama, C.-M.

“…Recombinant activated factor VII (rFVIIa) is indicated in bleeding patients when a life-threatening haemorrhage occurs. Prothrombin complex concentrates (PCCs)…”
Get full text

Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study by GODIER, A., MAZOYER, E., CYMBALISTA, F., CUPA, M., SAMAMA, C.‐M.

“…Background: Recombinant activated factor VII (rFVIIa) is increasingly used to secure hemostasis in hemorrhagic situations in trauma and surgical patients…”
Get full text

The use of contrast media in deceased kidney donors does not affect initial graft function or graft survival by Vigneau, C., Fulgencio, J.-P., Godier, A., Chalem, Y., El Metaoua, S., Rondeau, E., Tuppin, P., Bonnet, F.

“…Patients receiving cadaveric kidney transplants often experience delayed graft function. As iodinated contrast media injection (ICMI), necessary for cerebral…”
Get full text